Xuewu Liu is the inventor of intratumoral chlorine dioxide injection therapy and holds the world’s most patents for chlorine dioxide medical applications. As CEO of Wanbincell, he leads global collaborations to advance safe, effective, and low-cost cancer treatments. His preclinical and clinical work spans over 10 countries, offering new hope to patients with solid tumors.